New psoriasis drug shows promise for clearer skin

NCT ID NCT03412747

Completed Disease control Sponsor: UCB Biopharma SRL Source: ClinicalTrials.gov ↗

Summary

This study tested a new medication called bimekizumab against an existing treatment, adalimumab, for adults with moderate to severe plaque psoriasis. It involved 478 participants and aimed to see which drug was better at clearing skin and improving symptoms. The study also monitored side effects to understand the safety of the treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Ps0008 004

Fremantle, Australia
Ps0008 005

Phillip, Australia
Ps0008 007

Hectorville, Australia
Ps0008 008

East Melbourne, Australia
Ps0008 009

Woolloongabba, Australia
Ps0008 010

Kogarah, Australia
Ps0008 203

Dresden, Germany
Ps0008 205

Osnabrück, Germany
Ps0008 207

Berlin, Germany
Ps0008 211

Hamburg, Germany
Ps0008 213

Mahlow, Germany
Ps0008 215

Lübeck, Germany
Ps0008 217

Schweinfurt, Germany
Ps0008 218

Bonn, Germany
Ps0008 220

Hamburg, Germany
Ps0008 251

Gyula, Hungary
Ps0008 252

Budapest, Hungary
Ps0008 254

Budapest, Hungary
Ps0008 255

Budapest, Hungary
Ps0008 256

Debrecen, Hungary
Ps0008 260

Szeged, Hungary
Ps0008 352

Gdansk, Poland
Ps0008 353

Szczecin, Poland
Ps0008 354

Warsaw, Poland
Ps0008 355

Bialystok, Poland
Ps0008 356

Lublin, Poland
Ps0008 359

Katowice, Poland
Ps0008 360

Lodz, Poland
Ps0008 362

Bialystok, Poland
Ps0008 363

Krakow, Poland
Ps0008 364

Nowa Sól, Poland
Ps0008 365

Wroclaw, Poland
Ps0008 366

Katowice, Poland
Ps0008 367

Wroclaw, Poland
Ps0008 371

Bydgoszcz, Poland
Ps0008 372

Lodz, Poland
Ps0008 373

Wroclaw, Poland
Ps0008 401

Saratov, Russia
Ps0008 405

Saint Petersburg, Russia
Ps0008 406

Yaroslavl, Russia
Ps0008 657

Waterloo, Canada
Ps0008 659

Calgary, Canada
Ps0008 660

Montreal, Canada
Ps0008 661

Peterborough, Canada
Ps0008 662

Toronto, Canada
Ps0008 663

Mississauga, Canada
Ps0008 664

Toronto, Canada
Ps0008 669

Windsor, Canada
Ps0008 670

Windsor, Canada
Ps0008 674

Winnipeg, Canada
Ps0008 700

Seoul, South Korea
Ps0008 702

Gwangju, South Korea
Ps0008 754

Taipei, Taiwan
Ps0008 755

Taipei, Taiwan
Ps0008 900

West Des Moines, Iowa, 50265, United States
Ps0008 905

Overland Park, Kansas, 66215, United States
Ps0008 906

Boca Raton, Florida, 33486, United States
Ps0008 908

East Windsor, New Jersey, 08520, United States
Ps0008 917

Troy, Michigan, 48084, United States
Ps0008 924

Houston, Texas, 77004, United States
Ps0008 925

Brighton, Massachusetts, 02135, United States
Ps0008 927

Los Angeles, California, 90033, United States
Ps0008 929

Portland, Oregon, 97223, United States
Ps0008 931

Dallas, Texas, 75231, United States
Ps0008 932

Oklahoma City, Oklahoma, 73112, United States
Ps0008 934

Washington D.C., District of Columbia, 20037, United States
Ps0008 935

Winston-Salem, North Carolina, 27104-35 20, United States
Ps0008 936

Tampa, Florida, 33624, United States
Ps0008 939

Danbury, Connecticut, 06810, United States
Ps0008 940

Beverly, Massachusetts, 01844, United States
Ps0008 943

San Luis Obispo, California, 93405, United States
Ps0008 945

Greer, South Carolina, 29650, United States
Ps0008 951

Houston, Texas, 77004, United States
Ps0008 955

San Diego, California, 92123, United States
Ps0008 957

Glendale, Arizona, 85308, United States
Ps0008 961

Rocky Mount, North Carolina, 27804, United States
Ps0008 967

Santa Monica, California, 90404, United States

Conditions

Explore the condition pages connected to this study.

CHRONIC PLAQUE PSORIASIS MODERATE TO SEVERE PLAQUE PSORIASIS